39052230|t|Postoperative Delirium and Neurocognitive Disorders: Updates for Providers Caring for Cancer Patients.
39052230|a|PURPOSE OF REVIEW: To provide up to date information on postoperative delirium and neurocognitive disorders in surgical cancer patients. RECENT FINDINGS: Established risk factors such as age, psychosocial factors, comorbidities, frailty and preexisting cognitive decline continue to exhibit associations with perioperative neurocognitive disorders (PND); novel risk factors identified recently include microbiome composition and vitamin D deficiency. Prevention measures include cognitive prehabilitation, perioperative geriatric assessment and multidisciplinary care, dexmedetomidine and multimodal analgesic techniques. Studies investigating ciprofol, remimazolam, esketamine, ramelteon and suvorexant have shown encouraging results. Controversy remains regarding the use of inhalational versus intravenous general anesthesia. Innovative approaches to address PND are a rapidly developing area of research, but more studies are needed to identify effective prevention and management interventions. Despite challenges and controversy in the field, implementation of best practice can reduce the detrimental impact of PND on patients, caregivers, and society at large.
39052230	0	22	Postoperative Delirium	Disease	MESH:D000071257
39052230	27	51	Neurocognitive Disorders	Disease	MESH:D019965
39052230	86	92	Cancer	Disease	MESH:D009369
39052230	93	101	Patients	Species	9606
39052230	159	181	postoperative delirium	Disease	MESH:D000071257
39052230	186	210	neurocognitive disorders	Disease	MESH:D019965
39052230	223	229	cancer	Disease	MESH:D009369
39052230	230	238	patients	Species	9606
39052230	356	373	cognitive decline	Disease	MESH:D003072
39052230	426	450	neurocognitive disorders	Disease	MESH:D019965
39052230	452	455	PND	Disease	MESH:D019965
39052230	532	541	vitamin D	Disease	MESH:D014808
39052230	672	687	dexmedetomidine	Chemical	MESH:D020927
39052230	747	755	ciprofol	Chemical	-
39052230	757	768	remimazolam	Chemical	MESH:C522201
39052230	770	780	esketamine	Chemical	MESH:C000629870
39052230	782	791	ramelteon	Chemical	MESH:C495910
39052230	796	806	suvorexant	Chemical	MESH:C551624
39052230	965	968	PND	Disease	MESH:D019965
39052230	1221	1224	PND	Disease	MESH:D019965
39052230	1228	1236	patients	Species	9606
39052230	Negative_Correlation	MESH:C551624	MESH:D009369
39052230	Negative_Correlation	MESH:D020927	MESH:D019965
39052230	Negative_Correlation	MESH:C000629870	MESH:D009369
39052230	Negative_Correlation	MESH:C522201	MESH:D009369
39052230	Negative_Correlation	MESH:C495910	MESH:D009369
39052230	Negative_Correlation	MESH:C495910	MESH:D000071257
39052230	Negative_Correlation	MESH:C495910	MESH:D019965
39052230	Negative_Correlation	MESH:C000629870	MESH:D019965

